These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 709897)

  • 1. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.
    Pullan PT; Burger HG; Johnston CI
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):273-8. PubMed ID: 709897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats.
    Janáky T; Laczi F; László FA
    Ann N Y Acad Sci; 1982; 394():116-27. PubMed ID: 6960751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged antidiuresis by 1-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production.
    Katayama S; Itabashi A; Yamaji T
    Endocrinol Jpn; 1980 Jun; 27(3):363-70. PubMed ID: 6254752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
    Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
    J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).
    Cobb WE; Spare S; Reichlin S
    Ann Intern Med; 1978 Feb; 88(2):183-8. PubMed ID: 626447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
    Tuschy U; Szeszat S; Meinhold J
    Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent diabetes insipidus associated with pregnancy: pathophysiology and therapy.
    Hughes JM; Barron WM; Vance ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):462-4. PubMed ID: 2915875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological half-life and organ distribution of [3H]1-deamino-8-D-arginine-vasopressin in the rat.
    László FA; Janáky T; Baláspiri L; Morgat JL
    J Endocrinol; 1981 Feb; 88(2):181-6. PubMed ID: 7205124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.